Ontario Industry Updates obio 9/29/14 Ontario Industry Updates obio 9/29/14 AvidBiologics Closes New Financing Round Read More Ontario Industry Updates obio 9/17/14 Ontario Industry Updates obio 9/17/14 AbCelex Technologies Inc. Secures an Additional $1 Million in Series A Financing Read More Ontario Industry Updates obio 9/13/14 Ontario Industry Updates obio 9/13/14 Entrepreneur redevelops one of life’s scariest tests Read More Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 Armour Therapeutics discovers synergies between prostate cancer treatment and conventional chemotherapy to treat aggressive tumours Read More Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 AbCelex Technologies Secures Two Million in Series A Financing Read More Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 Kevin Egan Joins Sernova as Chair Business Advisory Board Read More Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 Interface Biologics Appoints Dion Madsen to Board of Directors Read More Ontario Industry Updates obio 5/8/14 Ontario Industry Updates obio 5/8/14 Sernova Announces Appointment of Nick Borrelly to Corporate Development Role Read More Ontario Industry Updates obio 4/28/14 Ontario Industry Updates obio 4/28/14 Sernova’s Cell Pouch™ Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility Read More Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14 Spectral Updates Status Of EUPHRATES Trial Read More Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14 Profound Medical Announces Closing of Enrollment Into TULSA Clinical Trial for Treatment of Localized Prostate Cancer Read More Ontario Industry Updates obio 4/9/14 Ontario Industry Updates obio 4/9/14 Critical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer Read More Ontario Industry Updates obio 3/26/14 Ontario Industry Updates obio 3/26/14 Dalton Pharma Services Announces Completion of a Major Expansion in Aseptic Filling Capabilities Read More Ontario Industry Updates obio 2/28/14 Ontario Industry Updates obio 2/28/14 Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law Read More Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14 Debiopharm Group™ to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics Read More Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14 Frank Holler Joins Sernova’s Board of Directors Read More Ontario Industry Updates obio 2/3/14 Ontario Industry Updates obio 2/3/14 Sernova Announces Appointment of Cathy Steiner as CFO Read More Ontario Industry Updates obio 12/15/13 Ontario Industry Updates obio 12/15/13 Stem Cell Therapeutics Completes $33 Million Private Placement Read More Ontario Industry Updates obio 11/27/13 Ontario Industry Updates obio 11/27/13 Sernova Corp Engages Carson Seabolt and Network IR Read More Ontario Industry Updates obio 7/9/13 Ontario Industry Updates obio 7/9/13 Sernova Receives Patent Allowance for Therapeutic Immune Privileged Cell Technologies Read More Newer Posts Older Posts
Ontario Industry Updates obio 9/29/14 Ontario Industry Updates obio 9/29/14 AvidBiologics Closes New Financing Round Read More
Ontario Industry Updates obio 9/17/14 Ontario Industry Updates obio 9/17/14 AbCelex Technologies Inc. Secures an Additional $1 Million in Series A Financing Read More
Ontario Industry Updates obio 9/13/14 Ontario Industry Updates obio 9/13/14 Entrepreneur redevelops one of life’s scariest tests Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 Armour Therapeutics discovers synergies between prostate cancer treatment and conventional chemotherapy to treat aggressive tumours Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 AbCelex Technologies Secures Two Million in Series A Financing Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 Kevin Egan Joins Sernova as Chair Business Advisory Board Read More
Ontario Industry Updates obio 5/16/14 Ontario Industry Updates obio 5/16/14 Interface Biologics Appoints Dion Madsen to Board of Directors Read More
Ontario Industry Updates obio 5/8/14 Ontario Industry Updates obio 5/8/14 Sernova Announces Appointment of Nick Borrelly to Corporate Development Role Read More
Ontario Industry Updates obio 4/28/14 Ontario Industry Updates obio 4/28/14 Sernova’s Cell Pouch™ Diabetes Clinical Trial Demonstrates Interim Safety and Biocompatibility Read More
Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14 Spectral Updates Status Of EUPHRATES Trial Read More
Ontario Industry Updates obio 4/18/14 Ontario Industry Updates obio 4/18/14 Profound Medical Announces Closing of Enrollment Into TULSA Clinical Trial for Treatment of Localized Prostate Cancer Read More
Ontario Industry Updates obio 4/9/14 Ontario Industry Updates obio 4/9/14 Critical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer Read More
Ontario Industry Updates obio 3/26/14 Ontario Industry Updates obio 3/26/14 Dalton Pharma Services Announces Completion of a Major Expansion in Aseptic Filling Capabilities Read More
Ontario Industry Updates obio 2/28/14 Ontario Industry Updates obio 2/28/14 Sernova Announces Annual Meeting, Record Date and Adopts Advance Notice By-Law Read More
Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14 Debiopharm Group™ to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics Read More
Ontario Industry Updates obio 2/12/14 Ontario Industry Updates obio 2/12/14 Frank Holler Joins Sernova’s Board of Directors Read More
Ontario Industry Updates obio 2/3/14 Ontario Industry Updates obio 2/3/14 Sernova Announces Appointment of Cathy Steiner as CFO Read More
Ontario Industry Updates obio 12/15/13 Ontario Industry Updates obio 12/15/13 Stem Cell Therapeutics Completes $33 Million Private Placement Read More
Ontario Industry Updates obio 11/27/13 Ontario Industry Updates obio 11/27/13 Sernova Corp Engages Carson Seabolt and Network IR Read More
Ontario Industry Updates obio 7/9/13 Ontario Industry Updates obio 7/9/13 Sernova Receives Patent Allowance for Therapeutic Immune Privileged Cell Technologies Read More
